Home › Neuroblastoma › Oregon › Portland
Neuroblastoma clinical trials in Portland, OR
6 studies for Neuroblastoma are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingPhase 3
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RecruitingPhase 1/2
- Oregon Health and Science University ( Site 1004), Portland
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
RecruitingPhase 2
- Randall Children's Hospital, Portland
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
RecruitingPhase 2
- Randall Children's Hospital, Portland
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RecruitingPhase 3
- Legacy Emanuel Children's Hospital, Portland
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
RecruitingPhase 2
- Randall Children's Hospital, Portland
About Neuroblastoma
Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.
More about Neuroblastoma on MedlinePlus
Neuroblastoma trials in other cities
- Boston, MA13 studies
- Washington, DC11 studies
- New York City, NY10 studies
- Memphis, TN9 studies
- St. Louis, MO9 studies
- Dallas, TX9 studies
- Philadelphia, PA9 studies
- Birmingham, AL8 studies
- Hartford, CT8 studies
- Aurora, CO8 studies
- Minneapolis, MN8 studies
- Miami, FL7 studies
Other studies in Portland
- Non-Small Cell Lung Cancer45 studies
- Cancer (all types)35 studies
- Prostate Cancer33 studies
- Breast Cancer32 studies
- Metastatic Cancer30 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Lung Cancer26 studies
- Endometrial Cancer25 studies
- Acute Myeloid Leukemia25 studies
- Head and Neck Squamous Cell Carcinoma19 studies
- Pancreatic Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.